Updated Jan 03, 2021 | 13:41 IST
Covaxin is a highly purified and inactivated 2 dose SARS-CoV2 vaccine, manufactured in a Vero cell manufacturing platform with an excellent safety track record of more than 300 million doses. Representational Image
Hyderabad: Expressing delight on the Ministry of Health & Family Welfare announcement and the statement from DCGI - Central Standards Control Organization (CDSCO) Grant of permission for emergency use of its Covid-19 Vaccine today, the Chairman and Managing Director of Bharat Biotech Dr Krishna Ella said “The approval of COVAXIN™ for emergency use is a giant leap for Innovation and novel product development in India. It is a proud moment for the nation and a great milestone in India’s scientific capability, a kickstart to the innovation ecosystem in India. While this vaccine addresses an unmet medical need during this pandemic, our goal is to provide global access to populations that need it the mo